Sign In

David Lowe

Co-Founder, Chairman and CEO at Delta TpX, Inc.

David Lowe is a distinguished seed stage investor and company builder, currently serving as Chairman and CEO of Delta TpX, a company devoted to developing targeted cancer therapy for patients with specific gene deletions.

In addition to his role at Delta TpX, David is the Co-Founder and Managing Director of AllosteRx Capital, an early-stage venture capital firm specializing in life sciences opportunities in under-ventured regions and institutions.

Prior to these ventures, David was the co-founder and CEO of Aeglea BioTherapeutics, focusing on enzyme replacement therapy for genetic rare diseases and cancer treatment.

David began his remarkable career at Genentech Inc. as a scientist and research leader, where he contributed significantly to drug discovery and development.

He holds both a PhD and BSc in biochemistry from the University of Toronto and is a Kauffman Fellow (Class 7).

D
Add to my network

Location

Austin, Texas